Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis

The aim of this study was to evaluate the effect of denosumab (Dmab) on bone mineral density (BMD) and bone turnover markers after 1 year of treatment. Additionally, the effect of Dmab in bisphosphonate-naïve patients (BP-naïve) compared to patients previously treated with bisphosphonates (BP-prior)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez, A., Brun, L. R., Salerni, H., Costanzo, P. R., González, D., Bagur, A., Oliveri, B., Zanchetta, M. B., Farías, V., Maffei, L., Premrou, V., Mansur, J. L., Larroudé, M. S., Sarli, M. A., Rey, P., Ulla, M. R., Pavlove, M. M., Karlsbrum, S., Brance, M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992763/
https://www.ncbi.nlm.nih.gov/pubmed/27579211
http://dx.doi.org/10.1155/2016/8738959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992763/
https://www.ncbi.nlm.nih.gov/pubmed/27579211
http://dx.doi.org/10.1155/2016/8738959

Ejemplares similares